Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

An embryonic CaVβ1 isoform promotes muscle mass maintenance via GDF5 signaling in adult mouse.

Traoré M, Gentil C, Benedetto C, Hogrel JY, De la Grange P, Cadot B, Benkhelifa-Ziyyat S, Julien L, Lemaitre M, Ferry A, Piétri-Rouxel F, Falcone S.

Sci Transl Med. 2019 Nov 6;11(517). pii: eaaw1131. doi: 10.1126/scitranslmed.aaw1131.

PMID:
31694926
2.

miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context.

Guilbaud M, Gentil C, Peccate C, Gargaun E, Holtzmann I, Gruszczynski C, Falcone S, Mamchaoui K, Ben Yaou R, Leturcq F, Jeanson-Leh L, Piétri-Rouxel F.

Skelet Muscle. 2018 Apr 27;8(1):15. doi: 10.1186/s13395-018-0161-2.

3.

Dystrophin's central domain forms a complex filament that becomes disorganized by in-frame deletions.

Delalande O, Molza AE, Dos Santos Morais R, Chéron A, Pollet É, Raguenes-Nicol C, Tascon C, Giudice E, Guilbaud M, Nicolas A, Bondon A, Leturcq F, Férey N, Baaden M, Perez J, Roblin P, Piétri-Rouxel F, Hubert JF, Czjzek M, Le Rumeur E.

J Biol Chem. 2018 May 4;293(18):6637-6646. doi: 10.1074/jbc.M117.809798. Epub 2018 Mar 13.

4.

RFX1 and RFX3 Transcription Factors Interact with the D Sequence of Adeno-Associated Virus Inverted Terminal Repeat and Regulate AAV Transduction.

Julien L, Chassagne J, Peccate C, Lorain S, Piétri-Rouxel F, Danos O, Benkhelifa-Ziyyat S.

Sci Rep. 2018 Jan 9;8(1):210. doi: 10.1038/s41598-017-18604-3.

5.

Delivery is key: lessons learnt from developing splice-switching antisense therapies.

Godfrey C, Desviat LR, Smedsrød B, Piétri-Rouxel F, Denti MA, Disterer P, Lorain S, Nogales-Gadea G, Sardone V, Anwar R, El Andaloussi S, Lehto T, Khoo B, Brolin C, van Roon-Mom WM, Goyenvalle A, Aartsma-Rus A, Arechavala-Gomeza V.

EMBO Mol Med. 2017 May;9(5):545-557. doi: 10.15252/emmm.201607199. Review.

6.

Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.

Rendu J, Montjean R, Coutton C, Suri M, Chicanne G, Petiot A, Brocard J, Grunwald D, Pietri Rouxel F, Payrastre B, Lunardi J, Dorseuil O, Marty I, Fauré J.

Hum Mutat. 2017 Feb;38(2):152-159. doi: 10.1002/humu.23139. Epub 2016 Nov 21.

PMID:
27790796
7.

Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles.

Peccate C, Mollard A, Le Hir M, Julien L, McClorey G, Jarmin S, Le Heron A, Dickson G, Benkhelifa-Ziyyat S, Piétri-Rouxel F, Wood MJ, Voit T, Lorain S.

Hum Mol Genet. 2016 Aug 15;25(16):3555-3563. doi: 10.1093/hmg/ddw201. Epub 2016 Jul 4.

PMID:
27378686
8.

Dystrophin Threshold Level Necessary for Normalization of Neuronal Nitric Oxide Synthase, Inducible Nitric Oxide Synthase, and Ryanodine Receptor-Calcium Release Channel Type 1 Nitrosylation in Golden Retriever Muscular Dystrophy Dystrophinopathy.

Gentil C, Le Guiner C, Falcone S, Hogrel JY, Peccate C, Lorain S, Benkhelifa-Ziyyat S, Guigand L, Montus M, Servais L, Voit T, Piétri-Rouxel F.

Hum Gene Ther. 2016 Sep;27(9):712-26. doi: 10.1089/hum.2016.041. Epub 2016 Jun 8.

PMID:
27279388
9.

Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy.

Relizani K, Mouisel E, Giannesini B, Hourdé C, Patel K, Morales Gonzalez S, Jülich K, Vignaud A, Piétri-Rouxel F, Fortin D, Garcia L, Blot S, Ritvos O, Bendahan D, Ferry A, Ventura-Clapier R, Schuelke M, Amthor H.

Mol Ther. 2014 Aug;22(8):1423-1433. doi: 10.1038/mt.2014.90. Epub 2014 May 27.

10.

Actin scaffolding by clathrin heavy chain is required for skeletal muscle sarcomere organization.

Vassilopoulos S, Gentil C, Lainé J, Buclez PO, Franck A, Ferry A, Précigout G, Roth R, Heuser JE, Brodsky FM, Garcia L, Bonne G, Voit T, Piétri-Rouxel F, Bitoun M.

J Cell Biol. 2014 May 12;205(3):377-93. doi: 10.1083/jcb.201309096. Epub 2014 May 5.

11.

Exon skipping as a therapeutic strategy applied to an RYR1 mutation with pseudo-exon inclusion causing a severe core myopathy.

Rendu J, Brocard J, Denarier E, Monnier N, Piétri-Rouxel F, Beley C, Roux-Buisson N, Gilbert-Dussardier B, Perez MJ, Romero N, Garcia L, Lunardi J, Fauré J, Fourest-Lieuvin A, Marty I.

Hum Gene Ther. 2013 Jul;24(7):702-13. doi: 10.1089/hum.2013.052.

12.

Variable phenotype of del45-55 Becker patients correlated with nNOSμ mislocalization and RYR1 hypernitrosylation.

Gentil C, Leturcq F, Ben Yaou R, Kaplan JC, Laforet P, Pénisson-Besnier I, Espil-Taris C, Voit T, Garcia L, Piétri-Rouxel F.

Hum Mol Genet. 2012 Aug 1;21(15):3449-60. doi: 10.1093/hmg/dds176. Epub 2012 May 15.

PMID:
22589245
13.

DHPR alpha1S subunit controls skeletal muscle mass and morphogenesis.

Piétri-Rouxel F, Gentil C, Vassilopoulos S, Baas D, Mouisel E, Ferry A, Vignaud A, Hourdé C, Marty I, Schaeffer L, Voit T, Garcia L.

EMBO J. 2010 Feb 3;29(3):643-54. doi: 10.1038/emboj.2009.366. Epub 2009 Dec 24.

14.

Is adipose tissue a place for Mycobacterium tuberculosis persistence?

Neyrolles O, Hernández-Pando R, Pietri-Rouxel F, Fornès P, Tailleux L, Barrios Payán JA, Pivert E, Bordat Y, Aguilar D, Prévost MC, Petit C, Gicquel B.

PLoS One. 2006 Dec 20;1:e43.

15.

Is oxygen a key factor in the lipodystrophy phenotype?

Gentil C, Le Jan S, Philippe J, Leibowitch J, Sonigo P, Germain S, Piétri-Rouxel F.

Lipids Health Dis. 2006 Oct 18;5:27.

16.

Oxygen consumption by cultured human cells is impaired by a nucleoside analogue cocktail that inhibits mitochondrial DNA synthesis.

Petit C, Piétri-Rouxel F, Lesne A, Leste-Lasserre T, Mathez D, Naviaux RK, Sonigo P, Bouillaud F, Leibowitch J.

Mitochondrion. 2005 Jun;5(3):154-61.

PMID:
16050981
17.

New series of N-substituted phenyl ketone oxime ethers: synthesis and bovine beta3-adrenergic agonistic activities.

El-Hadri A, Nicolle E, Leclerc G, Pietri-Rouxel F, Strosberg AD, Archimbault P.

Pharmazie. 2003 Jan;58(1):13-7.

PMID:
12622245
18.

Human adipose cells express CD4, CXCR4, and CCR5 [corrected] receptors: a new target cell type for the immunodeficiency virus-1?

Hazan U, Romero IA, Cancello R, Valente S, Perrin V, Mariot V, Dumonceaux J, Gerhardt CC, Strosberg AD, Couraud PO, Pietri-Rouxel F.

FASEB J. 2002 Aug;16(10):1254-6. Epub 2002 Jun 21. Erratum in: FASEB J 2002 Oct;16(12):4.

PMID:
12153994
19.

Synthesis and bovine beta 3-adrenergic agonistic activities of a novel series of aryloxypropanolamines.

el Hadri A, Nicolle E, Guillaume MC, Leclerc G, Pietri-Rouxel F, Strosberg AD, Archimbault P.

Pharmazie. 2001 Jul;56(7):517-22.

PMID:
11487967
20.

Genomic cloning and species-specific properties of the recombinant canine beta3-adrenoceptor.

Lenzen G, Pietri-Rouxel F, Drumare MF, Amiard A, Guillot S, Archimbault P, Strosberg AD.

Eur J Pharmacol. 1998 Dec 18;363(2-3):217-27.

PMID:
9881593
21.

Site-directed mutagenesis of the human beta3-adrenoceptor--transmembrane residues involved in ligand binding and signal transduction.

Gros J, Manning BS, Pietri-Rouxel F, Guillaume JL, Drumare MF, Strosberg AD.

Eur J Biochem. 1998 Feb 1;251(3):590-6.

22.

The biochemical effect of the naturally occurring Trp64-->Arg mutation on human beta3-adrenoceptor activity.

Piétri-Rouxel F, St John Manning B, Gros J, Strosberg AD.

Eur J Biochem. 1997 Aug 1;247(3):1174-9.

23.

Human immortalized brown adipocytes express functional beta3-adrenoceptor coupled to lipolysis.

Zilberfarb V, Piétri-Rouxel F, Jockers R, Krief S, Delouis C, Issad T, Strosberg AD.

J Cell Sci. 1997 Apr;110 ( Pt 7):801-7.

24.

Function and regulation of the beta 3-adrenoceptor.

Strosberg AD, Pietri-Rouxel F.

Trends Pharmacol Sci. 1996 Oct;17(10):373-81. Review.

PMID:
8979772
25.

Molecular cloning and pharmacological characterization of the bovine beta 3-adrenergic receptor.

Piétri-Rouxel F, Lenzen G, Kapoor A, Drumare MF, Archimbault P, Strosberg AD, Manning BS.

Eur J Biochem. 1995 May 15;230(1):350-8.

26.

Long term phorbol ester treatment down-regulates the beta 3-adrenergic receptor in 3T3-F442A adipocytes.

Fève B, Piétri-Rouxel F, el Hadri K, Drumare MF, Strosberg AD.

J Biol Chem. 1995 May 5;270(18):10952-9.

27.

Pharmacological characteristics and species-related variations of beta 3-adrenergic receptors.

Pietri-Rouxel F, Strosberg AD.

Fundam Clin Pharmacol. 1995;9(3):211-8. Review.

PMID:
7557816
28.

The inositol 1,4,5-trisphosphate receptor: kinetic properties and regulation.

Mauger JP, Lièvremont JP, Piétri-Rouxel F, Hilly M, Coquil JF.

Mol Cell Endocrinol. 1994 Jan;98(2):133-9.

PMID:
8143922
29.

Thiol reagents increase the affinity of the inositol 1,4,5-trisphosphate receptor.

Hilly M, Piétri-Rouxel F, Coquil JF, Guy M, Mauger JP.

J Biol Chem. 1993 Aug 5;268(22):16488-94.

Supplemental Content

Loading ...
Support Center